Find in Library

A new promising risk stratifying tool based on combination of lymphovascular invasion and systemic immune-inflammation index to predict the survival and to help evaluate the potential benefit of adjuvant chemotherapy for upper tract urothelial carcinoma

oleh: H-C. Jan, C-Y. Hu, W-H. Yang, C-H. Ou